|
|
Product Description
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing -- atom by atom -- both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS.You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.
Features
- Used Book in Good Condition
Customers Who Bought This Item Also Bought
- Molecules That Matter
- New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients
- From Alchemy to IPO
- The Antidote: Inside the World of New Pharma
- The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines
- The Pharmagellan Guide to Biotech Forecasting and Valuation
- Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer
- Science Lessons: What the Business of Biotech Taught Me About Management
- Genentech: The Beginnings of Biotech (Synthesis)
- The Antidote: Inside the World of New Pharma
*If this is not the "The Billion Dollar Molecule: One Company's Quest for the Perfect Drug" product you were looking for, you can check the other results by clicking this link
.
Details were last updated on Nov 12, 2024 09:30 +08.
